This study is evaluating whether sulforaphane may improve core symptoms in autism.
4 Primary · 3 Secondary · Reporting Duration: Week 4, week 10, week 18 and week 22.
Experimental Treatment
Non-Treatment Group
48 Total Participants · 2 Treatment Groups
Primary Treatment: Sulforaphane · Has Placebo Group · Phase 2
Age 13 - 30 · Male Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Missouri | 100.0% |
18 - 65 | 100.0% |
Rutgers University - Staged Research Building | 100.0% |
Did not meet criteria | 100.0% |